De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Chemed Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Chemed heeft een totaal eigen vermogen van $1.2B en een totale schuld van $0.0, wat de schuld-eigenvermogensverhouding op 0% brengt. De totale activa en totale passiva bedragen respectievelijk $1.7B en $527.7M. De EBIT Chemed is $366.3M waardoor de rentedekking -30.3 is. Het heeft contanten en kortetermijnbeleggingen van $222.9M.
Belangrijke informatie
0%
Verhouding schuld/eigen vermogen
US$0
Schuld
Rente dekkingsratio | -30.3x |
Contant | US$222.90m |
Aandelen | US$1.21b |
Totaal verplichtingen | US$527.69m |
Totaal activa | US$1.73b |
Recente financiële gezondheidsupdates
Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet
Jun 07Is Chemed (NYSE:CHE) Using Too Much Debt?
Jan 05Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?
Oct 01Recent updates
Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future
Aug 26Chemed Remains A Buy On Long-Term Economics
Aug 16Chemed Corporation's (NYSE:CHE) Shares May Have Run Too Fast Too Soon
Jul 19Chemed: Growth Does Not Justify The Current Stock Price
May 20Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns
May 14Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?
Apr 26Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year
Mar 01The Price Is Right For Chemed Corporation (NYSE:CHE)
Dec 30Chemed: Continues To Compound Shareholder Value At Double-Digit Returns
Nov 30Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns
Oct 26Chemed - Showcasing Why It's So Reliable
Aug 26Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked
Aug 13Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?
Aug 01Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future
Jul 14Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet
Jun 07Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns
Apr 09Chemed Q4 2022 Earnings Preview
Feb 22Chemed Corporation: Long-Term Tailwinds, But Remains A Hold
Feb 14Is Chemed (NYSE:CHE) Using Too Much Debt?
Jan 05Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean
Dec 17Chemed declares $0.38 dividend
Nov 04Chemed Q3 2022 Earnings Preview
Oct 28Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?
Oct 01Capital Investment Trends At Chemed (NYSE:CHE) Look Strong
Sep 16Buy Chemed To Reduce Equity Beta And Stabilize Portfolio Returns
Aug 26A Look At The Intrinsic Value Of Chemed Corporation (NYSE:CHE)
Aug 16Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $464.6M ) CHE } overtreffen de korte termijn passiva ( $261.8M ).
Langlopende schulden: De kortetermijnactiva CHE ( $464.6M ) overtreffen de langetermijnschulden ( $265.9M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: CHE is schuldenvrij.
Schuld verminderen: CHE heeft geen schulden vergeleken met 5 jaar geleden, toen de schuld/eigen vermogen-ratio 13.7% was.
Schuldendekking: CHE heeft geen schulden en hoeft daarom niet gedekt te worden door de operationele kasstroom.
Rentedekking: CHE heeft geen schulden, dus de dekking van rentebetalingen is geen probleem.